Variegated overexpression of chromosome 21 genes reveals molecular and immune subtypes of Down syndrome
2024 · Nature Communications · 20 citations
https://doi.org/10.1038/s41467-024-49781-1
N
Neetha Paul Eduthan
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
66
Papers
259
Citations
7
h-index
6
i10-index
Neetha Paul Eduthan is an academic researcher from University of Colorado Anschutz Medical Campus. The author has contributed to research in topics: Ubiquitin and proteasome pathways & Protein Degradation and Inhibitors & Down syndrome and intellectual disability research. The author has an h-index of 7, co-authored 57 publications.
ORCID: 0009-0002-6351-0051Papers by this author
worksMultimodal analysis of dysregulated heme metabolism, hypoxic signaling, and stress erythropoiesis in Down syndrome
2024 · Cell Reports · 8 citations
https://doi.org/10.1016/j.celrep.2024.114599
Data from Proteasome Inhibition Sensitizes Liposarcoma to MDM2 Inhibition with Nutlin-3 by Activating the ATF4/CHOP Stress Response Pathway
2024 · 0 citations
https://doi.org/10.1158/0008-5472.c.6769314.v2
Supplementary File 1 from Proteasome Inhibition Sensitizes Liposarcoma to MDM2 Inhibition with Nutlin-3 by Activating the ATF4/CHOP Stress Response Pathway
2024 · 0 citations
https://doi.org/10.1158/0008-5472.27027910.v1
Supplementary File 3 from Proteasome Inhibition Sensitizes Liposarcoma to MDM2 Inhibition with Nutlin-3 by Activating the ATF4/CHOP Stress Response Pathway
2024 · 0 citations
https://doi.org/10.1158/0008-5472.27027904.v1
Supplementary File 6 from Proteasome Inhibition Sensitizes Liposarcoma to MDM2 Inhibition with Nutlin-3 by Activating the ATF4/CHOP Stress Response Pathway
2024 · 0 citations
https://doi.org/10.1158/0008-5472.27027895.v1
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat